Our story - SVI Board
SVI Board
Ms Brenda M Shanahan
BEc BComm
Chair, SVI Board
Ms Shanahan has a research background in finance in Australian and overseas economies and share markets. She is Chair of Challenger Listed Investments and a non-Executive Director of Clinuvel Pharmaceuticals Ltd; DMP Asset Management Ltd and Kimberley Foundation of Australia Ltd. She is a former Chairman of St. Vincent’s Health Ltd, former member of the Australian Stock Exchange, and former Executive Director of a stockbroking firm, a fund management company and an actuarial company.
Dr Susan M Alberti AO
HonLLD
Dr Alberti is co-founder and Managing Director of DANSU Group and associated companies. She has a strong commitment to fundraising and promotion of juvenile diabetes and is the National President of the Juvenile Diabetes Research Foundation Australia and also International Patron and member of the Board of Chancellors of JDRF International. Dr Alberti is Chair of the SVI Foundation, Victoria University Foundation Board member and also a Board member of the Western Bulldogs and Co-Chair of the Western Bulldogs Forever Foundation.
Mr Paul Holyoake
BEngMech (Hons) MEngSci
Mr Holyoake is currently Executive Chairman, Oakton Limited, an ASX listed, information technology services company.
From June 1988 to June 2005, Mr Holyoake was Managing Director and Chief Executive Officer, Oakton Limited.
Professor Thomas WH Kay
BMedSc MBBS PhD Melb FRACP FRCPA
Professor Kay is Director of SVI. He holds a Professorial appointment within the Department of Medicine, St. Vincent’s Hospital and The University of Melbourne. He also holds the position of Honorary Endocrinologist at St. Vincent’s Hospital. Professor Kay’s research interests are in the area of autoimmunity, particularly of type 1 (juvenile) diabetes.
Mr John T Macfarlane
MComm
Mr Macfarlane is Chairman of Deutsche Bank Group, Australia & New Zealand following seven years as President & CEO of Deutsche Bank, Japan. An economist by training, Mr Macfarlane held senior positions with Bankers Trust in Sydney, New York and New Zealand until its acquisition by Deutsche Bank in 1999. He has served as: Director of the NZFE; member of the Global Markets Executive Committee, the Global Banking Executive Committee and the Global Regional Management Committee of Deutsche Bank; and Co-Chair of the Asia Pacific Deutsche Bank Executive Management Committee.
Mr Stephen Marks
FCA
Mr Marks is the Managing Director of Stephen G.Marks & Co. Pty. Ltd. He is a Fellow of the Institute of Chartered Accountants and a Fellow of The Institute of Company Directors in Australia. He was formerly Chairman of the Sothertons Chartered Accountants National Board and Managing Partner of the Melbourne office. He has recently retired as the Director of Probity Services for RSM Bird Cameron. He is a member of the Audit Committee of Orygen Youth Health and the Investment Advisory Committee of DMP Asset Management Ltd.
Mr Michael McGinniss
BComm (Hons) MEc
Mr McGinniss retired from a senior position as a partner with PricewaterhouseCoopers, Chartered Accountants in 2000. Since then he has taken up a number of Board positions in the not-for-profit and commercial sectors and also serves as a Trustee of The Marian & EH Flack Trust.
Professor Patricia O'Rourke
RN, Grad Dip App Sc (Nursing), GAICD
Professor O’Rourke was appointed St. Vincent's Chief Executive Officer in April 2009. She has more than 20 years experience in the healthcare industry, including nursing and senior management roles. In her previous role as Chief of Clinical Operations and Chief Nursing Officer at St. Vincent’s her duties included leading regional and national projects, representing St. Vincent’s on a number of Department of Human Services committees, providing strategic and operational advice to the CEO and clinical leadership to the Executive. Until October 2008 she was a member of the Board of Southern Health.
Ms Ruth O'Shannassy
BComm
Ms O'Shannassy worked in economic research in the finance industry in Melbourne before moving overseas. She spent seven years living and working offshore, primarily as a stockbroker in London and Asia before returning to Australia.
Ms O'Shanassy is a Board member of the Victorian Prostate Cancer Research Consortium.
Mr Gregory Robinson
BSc(Hons) MBA (Columbia)
Mr Robinson was appointed Managing Director and Chief Executive Officer of Newcrest Mining Limited in July 2011 following almost 5 years as the company's Director of Finance, responsible for the Group's finance function, strategy, planning and business development activities. Prior to joining Newcrest, Mr Robinson was with the BHP Billiton Group for the period 2001 to 2006 where he held the positions of Project Director of the Corporation Alignment Project, Chief Finance and Chief Development Officer, Energy and Chief Financial Officer, Petroleum. He was also a member of the Energy Executive Committee and Group Executive Committee. Before joining BHP Billiton, Mr Robinson was Director of Investment Banking at Merrill Lynch & Co and headed the Asia Pacific Metals and Mining Group.
Professor James Best
MBBS, MD, FRACP, FRCPath, FRCP Edin, MD (Hon, St Andrews)
Professor Best is Professor of Medicine and Head of the Melbourne Medical School at the University of Melbourne. He is Chair of Australia’s National Health and Medical Research Council (NHMRC) Research Committee and a member of the Council. Professor Best is a member of the National Heart Foundation Research Committee, Chair of the Victorian Prostate Cancer Research Consortium and the Victorian Medical Insurance Agency, and inaugural Chair of the Steering Committee of the Australian Type 1 Diabetes Clinical Research Network. Professor Best has previously been a Board Member of three different metropolitan health services in Melbourne, including St Vincent’s Health.